Suppr超能文献

[甲状腺切除术后低钙血症:基于甲状旁腺激素和钙水平的发生率、预测及门诊管理策略]

[Post-Thyroidectomy Hypocalcemia: Incidence, Prediction, and Outpatient Management Strategies Based on PTH and Calcium Levels].

作者信息

Cabané Patricio, Castro Ana, Rodríguez Francisco, Cavada Gabriel

机构信息

Centro de Tiroides y Paratiroides, Clínica Indisa, Santiago, Chile.

Clínica Indisa, Santiago, Chile.

出版信息

Rev Med Chil. 2023 Jul;151(7):920-928. doi: 10.4067/s0034-98872023000700920.

Abstract

INTRODUCTION

PTH measurement has been proposed to predict transient and permanent postoperative hypocalcemia. There is no standard cut-off point or time for sampling.

AIM

To report the incidence of post-thyroidectomy hypocalcemia in a high-volume surgical group and propose an outpatient management protocol according to postoperative (PO) calcium levels, iPTH (normal, low, or undetectable), and symptoms. Furthermore, determine postoperative PTH values as predictors of hypocalcemia.

METHODS

In 106 patients with total thyroidectomy between 2019 and 2021, pre-and postoperative levels of calcium, magnesium, phosphorus, and iPTH were measured.

RESULTS

Transient (< 12 months) and permanent (> 12 months) hypocalcemia was observed in 29% and 1%. Cut-off points to predict hypocalcemia were PTH < 8.8 pg/mL and < 80% decrease in % PTH (d% PTH) the day after surgery. With the proposed management, early discharge is indicated (an average of 1.05 days), and the prescription cost is limited. There is no significant association between PO hypomagnesemia and hyperphosphatemia with PO hypocalcemia. The most widely used treatment is exclusive calcium carbonate (schemes I and II). Patients remain with mild symptoms at two weeks PO in 5% and discontinue oral treatment in 93% in this period.

CONCLUSIONS

Protocols for measuring PTH as a hypocalcemia predictor vary. Each center must know and establish its management protocols. With this experience, we demonstrate the usefulness and safety of a management scheme based on calcium, PTH (normal, low, or undetectable), and symptoms with an indication of prophylactic treatment for all patients and a safe outpatient setting at a lower cost than prolonged hospitalization.

摘要

引言

有人提出通过检测甲状旁腺激素(PTH)来预测术后短暂性和永久性低钙血症。目前尚无标准的采样临界点或采样时间。

目的

报告在一个大型手术组中甲状腺切除术后低钙血症的发生率,并根据术后(PO)血钙水平、iPTH(正常、低或不可检测)及症状提出门诊管理方案。此外,确定术后PTH值作为低钙血症的预测指标。

方法

对2019年至2021年间106例行全甲状腺切除术的患者,测定术前及术后的钙、镁、磷和iPTH水平。

结果

观察到短暂性(<12个月)和永久性(>12个月)低钙血症的发生率分别为29%和1%。预测低钙血症的临界点为术后第1天PTH<8.8 pg/mL及PTH降低百分比(d%PTH)<80%。采用所提出的管理方案,可实现早期出院(平均1.05天),且处方成本有限。PO期低镁血症和高磷血症与PO期低钙血症之间无显著关联。最常用的治疗方法是单纯碳酸钙(方案I和II)。在此期间,5%的患者在术后两周仍有轻微症状,93%的患者在此期间停止口服治疗。

结论

作为低钙血症预测指标的PTH测量方案各不相同。每个中心都必须了解并制定自己的管理方案在此经验基础上,我们证明了基于钙、PTH(正常、低或不可检测)及症状的管理方案的有效性和安全性,该方案可为所有患者提供预防性治疗,并在门诊安全实施,成本低于延长住院时间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验